Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, and NuShield® product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC) Fall Conference held October 29-31 in Las Vegas, Nev.

Attendees of this year’s event are encouraged to visit the Organogenesis-supported lunch symposium, “New Scientific Data Supporting the Use of an Antimicrobial Native Collagen ECM and Real-World Case Studies Highlighting a Treatment Algorithm Approach​” held Friday, Oct. 29, from 11:40 a.m. – 1:10 p.m. PST in the Innovation Theatre … read more

Newsletter Signup

Subscribe to our weekly newsletter below for an update of everything from the week